The burden, trends, and demographics of mortality from subarachnoid hemorrhage.
about
Endothelin receptor antagonists for subarachnoid hemorrhageEndothelin receptor antagonist for subarachnoid haemorrhageEndovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid haemorrhageIncidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trendsRegional variation in hospitalization for stroke among Asians/Pacific Islanders in the United States: a nationwide retrospective cohort study.Personalized Medicine in Cerebrovascular Neurosurgery: Precision Neurosurgical Management of Cerebral Aneurysms and Subarachnoid HemorrhageThe importance of early brain injury after subarachnoid hemorrhageInflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm researchCerebral vasospasm after subarachnoid hemorrhage: the emerging revolutionExtravascular optical coherence tomography: evaluation of carotid atherosclerosis and pravastatin therapy17-beta estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage.Subarachnoid hemorrhage: tests of association with apolipoprotein E and elastin genes.Risks of subarachnoid hemorrhage in siblings: a nationwide epidemiological study from Sweden.Identification of six polymorphisms as novel susceptibility loci for ischemic or hemorrhagic stroke by exome-wide association studies.The association between lunar phase and intracranial aneurysm rupture: Myth or reality? Own data and systematic reviewNovel Actions of Nonsteroidal Anti-Inflammatory Drugs on Vascular Ion Channels: Accounting for Cardiovascular Side Effects and Identifying New Therapeutic Applications.Role of magnesium sulfate in aneurysmal subarachnoid hemorrhage management: A meta-analysis of controlled clinical trials.Should we be screening relatives of patients with aneurysmal subarachnoid hemorrhage for asymptomatic intracranial aneurysm?Interpretation of traumatic lumbar punctures in the setting of possible subarachnoid hemorrhage: who can be safely discharged?Application of proteomics to cerebrovascular disease.Introducing a nationwide registry: the Swiss study on aneurysmal subarachnoid haemorrhage (Swiss SOS).Imatinib preserves blood-brain barrier integrity following experimental subarachnoid hemorrhage in ratsCurrent practice in neuropsychological outcome reporting after aneurysmal subarachnoid haemorrhage.From GWAS to the clinic: risk factors for intracranial aneurysms.Meteorological influences on the incidence of aneurysmal subarachnoid hemorrhage - a single center study of 511 patientsRisk of intracranial hemorrhage associated with autosomal dominant polycystic kidney disease in patients with end stage renal disease.Regulation of microRNAs miR-30a and miR-143 in cerebral vasculature after experimental subarachnoid hemorrhage in rats.MEK1/2 inhibitor U0126 but not endothelin receptor antagonist clazosentan reduces upregulation of cerebrovascular contractile receptors and delayed cerebral ischemia, and improves outcome after subarachnoid hemorrhage in rats.Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage.Molecular basis and genetic predisposition to intracranial aneurysm.Molecular mechanisms of the formation and progression of intracranial aneurysms.Subarachnoid hemorrhage: who dies, and why?Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage.Experimental subarachnoid haemorrhage results in multifocal axonal injury.Current diagnostic approaches to subarachnoid haemorrhage.The effects of continuous prostacyclin infusion on regional blood flow and cerebral vasospasm following subarachnoid haemorrhage: study protocol for a randomised controlled trialImpact of electrolyte imbalances on the outcome of aneurysmal subarachnoid hemorrhage: A prospective study.Cerebral vasospasm pharmacological treatment: an updateDevelopments in the management of autosomal dominant polycystic kidney disease.Year in review 2011: Critical Care--Neurocritical care.
P2860
Q24200327-64AA8BCE-393B-4A18-9D4D-7F167BDF8027Q24240214-D093BB92-B554-4993-9577-F5B827D6171AQ24245594-18686AD9-CA26-4091-BBA9-52FE9A300F33Q24669798-EA780EBA-F984-4F47-BED7-12B26FEEFA5BQ24815205-E0AA1987-BA02-4505-8D44-AA515B93DCE1Q26742076-9065D7F6-EEFA-424C-9277-DE92589AEBB4Q27028040-27BED24B-87CF-4C8C-935E-6BD933758D63Q28084855-5DC85448-7100-4909-8D34-7B1FE2A65C33Q28300542-BAE09360-C13F-4FDE-80A7-2BA981A2C62CQ30575114-9AB079E9-5EAC-4B8D-85FB-BEE706B6C495Q30652313-A51D323E-122B-43B9-84AC-F6C5EA887670Q33292908-F8B0C3A2-B2F1-4B5E-8069-E2929236E3FBQ33668843-C9CC8E7B-BAC6-4EDF-9C8C-71E8B1780754Q33675091-41E3ED89-A3BA-47E6-AF7B-D5B2D9DA1CB1Q33706431-C494BA70-84D4-4202-B398-DBF3CD5C82E4Q34043009-238DAEBD-9C5A-4579-ACB6-B59E9FF418B2Q34068557-F08685B4-0B14-480D-B411-4F72385A2EACQ34107341-A64AA441-CF03-4430-ADEC-1D25FFF1F4EEQ34113603-D5BF6CD8-5B57-4FAC-A172-84796C1D80CEQ34312457-A103DCC0-3F4C-41E0-979F-0928EC95A71DQ34439961-014D87C7-E89A-4CA5-9061-BC5420E28206Q34543944-1AD57BFC-7DBC-426A-A87E-E2BA98F57B66Q34866884-D99F5A30-1D04-425B-9D66-BD8030942273Q34971540-0214C9B6-F9FB-493C-B38B-F47944225A0CQ35061272-1ABA1EA6-8359-4AB9-AFAB-6C466AD2AAFEQ35103239-7AC7B587-4385-4965-8169-84B1436BB071Q35576268-B4C045FE-AF42-40D4-AE4F-7CDBA5DBBC52Q35591265-3589CED0-12A4-4EA5-A583-CFA431BC8B4AQ35608589-1596EA45-6C0B-4904-9BDF-A8D7A11A2E55Q35626453-453098E0-F886-4FF7-A425-C12B484A5B4AQ35943389-FCADFA19-D68C-4940-9E7D-797BAD03356FQ36015756-4E76D967-E976-4666-9FED-8E15B456B921Q36025124-C724E69E-5597-415B-9DDD-8636380E82B3Q36041412-91F418B8-DC44-43FC-A1FA-9B889B0FCA0AQ36042386-939C4C96-5455-4721-9613-D921625F138FQ36367771-A432CB01-9CB1-4DC0-AAD3-BDA89F5EB2F8Q36518408-EADBBD37-8BB3-4420-BA3F-1CBF9085B6CFQ36610442-612425B8-54E6-4030-B184-FC9B1279E807Q36823578-2AFFBD7C-19D6-4268-B810-7446FD73D158Q36902672-918054B3-3D97-4B2A-A6D1-1993F4F68541
P2860
The burden, trends, and demographics of mortality from subarachnoid hemorrhage.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
The burden, trends, and demographics of mortality from subarachnoid hemorrhage.
@en
The burden, trends, and demographics of mortality from subarachnoid hemorrhage.
@nl
type
label
The burden, trends, and demographics of mortality from subarachnoid hemorrhage.
@en
The burden, trends, and demographics of mortality from subarachnoid hemorrhage.
@nl
prefLabel
The burden, trends, and demographics of mortality from subarachnoid hemorrhage.
@en
The burden, trends, and demographics of mortality from subarachnoid hemorrhage.
@nl
P2093
P356
P1433
P1476
The burden, trends, and demographics of mortality from subarachnoid hemorrhage.
@en
P2093
P304
P356
10.1212/WNL.50.5.1413
P407
P577
1998-05-01T00:00:00Z